Biotechnology News and Research

RSS

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

Researchers at The University of Nottingham, England have picked up almost £1 million in funding for a number of studies into a painful and distressing bowel condition that will affect up to one in 10 of the population at some time or another.

11 May 2004

GenoMed adds to management team

GenoMed, Inc., a Next Generation Disease Management™ company that uses its expertise in genes to improve patient outcomes, said today that it has hired three additional full-time employees: a Chief Financial Officer, a Vice President for Marketing, and a Chief Technical Officer.

11 May 2004

Scientists tackle the decline in male fertility

This week, Australian scientists will gather at The University of Queensland’s Institute for Molecular Bioscience (IMB) to discuss the causes of an alarming decline in male fertility in Australia and worldwide.

11 May 2004

Europe-wide network fighting heart disease

Academic expertise at the University of Birmingham's Medical School is contributing to a Europe-wide network fighting heart disease. The European Vascular Genomics Network (EVGN) is the first European Funded network of excellence in the field of cardiovascular disease.

10 May 2004

Discovery of immune system malfunction that plays a profound role in food allergy

A team of scientists, led by the Institute of Food Research (IFR) in the UK, has discovered an immune system malfunction that is likely to play a profound role in food allergy.

8 May 2004

Graduate program to address US nursing shortage

Jennifer Thompson, 38, left behind a lucrative career in pharmaceutical sales to become a nurse. She is one of 21 students enrolled in the University of New Hampshire's new direct entry master's in nursing program that is answering the call to fill the state and national need for more nurses prepared at higher levels of education.

6 May 2004

Agreement expands Quintiles capabilities to support drug approvals in Japan

Quintiles Transnational Corp. today announced an agreement to conduct clinical trials in Peru involving ethnic Japanese, further expanding the company's ability to support new drug applications in Japan.

5 May 2004

Radiologists use CT-Scans to inject gene therapy into tumors

Using CT-scan images to steer gene-therapy injections directly into the tumor offers a safe delivery method for treating patients with metastatic kidney cancer, report UCLA radiologists in the May issue of Radiology. Their findings could enhance the treatment of the disease, which resists traditional intravenous chemotherapy in 85 percent of cases.

4 May 2004

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Pharmaceutical science leaders from the FDA, research institutions and top pharmaceutical companies will gather at the 2004 AAPS National Biotechnology Conference, AAPS' spring annual meeting.

4 May 2004

Study shows those with weak immune systems should avoid the shower

A study out of the San Diego State University Center for Microbial Sciences reveals that hundreds of millions of colorful bacteria thrive on shower curtains, waiting to attack those who think they are getting clean.

3 May 2004

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).

2 May 2004

Protein expression of the tumor suppressing gene could play a vital role in ovarian cancer

Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University

1 May 2004

Results look promising in Alzheimer’s gene therapy trial

Surgical placement of genetically modified tissue directly into the brains of patients with Alzheimer’s disease, an experimental approach to delaying brain cell loss associated with the disease, leads to increased metabolic activity in the brain, with cells apparently responding to the insertion of growth factor-producing grafts

28 Apr 2004

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

Researchers are beginning to see the potential for breakthrough in healthcare through glycomics, which studies carbohydrates, proteins and their interactions. In fact, these carbohydrates are moving beyond their regular roles as sugar storage bins.

28 Apr 2004

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

Prana Biotechnology Limited has announced that it entered into definitive agreements with new institutional investors for the purchase of US$20 million of securities through the sale of 4 million ADR's at US$5.00 per ADR.

28 Apr 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004

Wyeth to appeal $1 billion awarded to the family of a woman who died after using fen-phen diet drug

Wyeth said today it will appeal today's verdict in the case of Jerry Coffey (representing the estate of Cynthia Cappel-Coffey), et al. v. Wyeth, et al.

27 Apr 2004

First generic cultivate(R) cream to receive tentative FDA approval

Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.

27 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

Clemson launches DNA learning center

Clemson University has teamed up with the nation's leading genetics learning center to help S.C. students and teachers understand the far-reaching impact genetics will have on the future.

22 Apr 2004

Biotechnology News and Research

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

GenoMed adds to management team

Scientists tackle the decline in male fertility

Europe-wide network fighting heart disease

Discovery of immune system malfunction that plays a profound role in food allergy

Graduate program to address US nursing shortage

Agreement expands Quintiles capabilities to support drug approvals in Japan

Radiologists use CT-Scans to inject gene therapy into tumors

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Study shows those with weak immune systems should avoid the shower

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

Protein expression of the tumor suppressing gene could play a vital role in ovarian cancer

Results look promising in Alzheimer’s gene therapy trial

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

Wyeth to appeal $1 billion awarded to the family of a woman who died after using fen-phen diet drug

First generic cultivate(R) cream to receive tentative FDA approval

SARS antibody sent to China

Clemson launches DNA learning center

Biotechnology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News